STOCK TITAN

Kyverna Therapeutics: GordonMD reports 7.34% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Kyverna Therapeutics, Inc. (KYTX) is the issuer named in an amended beneficial-ownership report by GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, GordonMD Long Biased GP LLC, Craig D. Gordon, and GordonMD Global Investments GP LLC. The report states that GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC each have shared voting and dispositive power over 4,521,318 shares (7.34%).

GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC each report shared voting and dispositive power over 4,198,616 shares (6.79%). The shares are directly owned by advisory clients of GordonMD Global Investments LP; the report identifies the master fund as the only such client that may be deemed to beneficially own more than 5% of KYTX common stock.

Beneficially owned shares 4,521,318 shares Each reported by GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC
Percent of class 7.34% Reported by GordonMD Global Investments LP, Craig D. Gordon, and GordonMD Global Investments GP LLC
Beneficially owned shares 4,198,616 shares Each reported by GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC
Percent of class 6.79% Reported by GordonMD Long Biased Master Fund LP and GordonMD Long Biased GP LLC
beneficially owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 4,521,318.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 4,521,318.00"
advisory clients financial
"All of the securities reported in this are directly owned by advisory clients"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KYTX shares did the reporting persons report owning?

Three reporting persons each reported beneficial ownership of 4,521,318 shares, or 7.34%; two reported 4,198,616 shares, or 6.79%. The report also lists shared voting and dispositive power for those positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





501976104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



GordonMD Global Investments LP
Signature:/s/ GordonMD Global Investments GP LLC
Name/Title:Craig D. Gordon, Managing Member of the General Partner
Date:11/16/2026
GordonMD Long Biased Master Fund LP
Signature:/s/ GordonMD Long Biased GP LLC
Name/Title:GordonMD Long Biased GP LLC, Managing Member of the General Partner
Date:11/16/2026
GordonMD Long Biased GP LLC
Signature:/s/ Craig D. Gordon
Name/Title:Craig D. Gordon, Managing Member
Date:11/16/2026
Craig D. Gordon
Signature:/s/ Craig D. Gordon
Name/Title:Craig D. Gordon
Date:11/16/2026
GordonMD Global Investments GP LLC
Signature:/s/ Craig D. Gordon
Name/Title:Craig D. Gordon, Managing Member
Date:11/16/2026
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

Keep reading